[25] Shaamash et al. [27] conducted a prospective, controlled, randomized trial (n = 320) comparing the levonorgestrel-20 µg intrauterine system Mirena (Bayer HealthCare Pharmaceuticals ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

Previous research by the same group demonstrated the effects of intrauterine exposure to the ... In addition, the mammalian ...

[29] Other medical alternatives are the Levonorgestrel-releasing intrauterine system (LNG-IUS) and GnRH-agonists. However, the LNG-IUS cannot be applied in case of significant distortion of the ...